1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Autoimmune Pancreatitis: new trials by email Literature Review of Autoimmune Pancreatitis trials Research Report on Autoimmune Pancreatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) EUS-FNB with ProCore needle, EUS-FNB with SharkCore needle, ProCore needle - Mesenchymal Tumor, Autoimmune Pancreatitis | Phase 2 | Withdrawn | Johns Hopkins University | 2016-04-01 | 2017-05-15 | |
| Rituximab in IgG4-RD: A Phase 1-2 Trial Rituximab - Retroperitoneal Fibrosis, Autoimmune Pancreatitis | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 30 | 2012-04-01 | 2017-07-02 |
Lymphadenopathy (1) · Lymphoma (1) · Meningitis (1) · Orbital Pseudotumor (1) · Retroperitoneal Fibrosis (1) · Sialadenitis (1)
Autoimmune Diseases (2) · Chronic Disease (2) · Digestive System Diseases (2) · Disease Attributes (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Lymphatic Diseases (2) · Pancreatic Diseases (2) · Pancreatitis (2) · Pancreatitis, Chronic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Eye Diseases (1) · Fibrosis (1) · Immunoproliferative Disorders (1)
Rituximab (1)
Johns Hopkins University (1) · Massachusetts General Hospital (1)
United States (1)
Arezou Khosroshahi, MD (1) · John H Stone, MD, MPH (1) · Mouen Khashab, MD (1)